We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA-Spotted Microarray Developed to Detect Bioterror Pathogens

By LabMedica International staff writers
Posted on 03 Sep 2008
Lethal diseases frequently spread faster than it takes to diagnose them in the laboratory. More...
To correct that, researchers have developed a test to bring that time from days down to hours.

Dr. Sanjeev Narayanan, assistant professor, and Dr. Greg Peterson, research microbiologist, both from the department of diagnostic medicine and path biology at Kansas State University (Manhattan, KS, USA), are using a device called a DNA-spotted microarray to pinpoint the specific genetic markers that distinguish one pathogen apart from another and determine antibiotic resistance.

Traditionally, it takes days and multiple lab workers to screen a sample of soil, water, or feces for just one pathogen. Additional time is then needed to look for resistance to antibiotics. The new test developed at Kansas State simultaneously looks for multiple diseases and antibiotic resistance, reducing the time it takes from sampling to diagnosis to about 24 hours. "We needed a mass, high through-put system,” Dr. Narayanan noted. "The longer a serious disease goes undiagnosed, the harder it is to treat, and the further it can spread.”

The researchers analyzed DNA of hundreds of pathogens and synthesized DNA probes for the specific genetic sequences that set each pathogen apart. Up to now, they can detect as many as 557 genes, making it possible for them to screen for 40 different species of bacteria, 1,200 serotypes of Salmonella, five common serotypes of Escherichia coli, and resistance to the 45 most common antibiotics used to treat human and animal illnesses caused by these pathogens.

When a sample is submitted, technicians extract and fluorescently label total DNA, and run a microarray to find out whether a particular gene is present. According to Dr. Narayanan, the next phase will be to develop a test that indicates how much of a pathogen is present.

Dr. Narayanan commented that he and Dr. Peterson developed the test because most human and animal infections are caused by a combination of pathogens. Under the current practice, it can take days to isolate and identify each individual pathogen and generate their antimicrobial resistance profiles. This means physicians and veterinarians often initiate antibiotic treatment before knowing precisely what the actual problem is.

"This new test will eliminate a lot of the guesswork,” Dr. Narayanan said. It will inform the doctor how many different kinds of pathogens are in a sample and which antibiotics would not work, all in a shorter time frame. The test's efficiencies also translate into lower cost, he reported.

Should the United States ever be attacked with biologic weapons the new test also would help in quickly identifying all of the bacterial pathogens used. "Being able to get such quick results for so many pathogens at once will become critical in case of bioterrorism,” Dr. Narayanan said. "Under that scenario, every minute counts in providing treatment or preventing disease spread.” Moreover, such pathogens would likely be engineered for resistance to common drug treatment, and the new test would determine such resistance rapidly, Dr. Narayanan reported.

The test is currently being used in research labs at Kansas State's College of veterinary medicine to detect animal and zoonotic pathogens; zoonotic pathogens can be transmitted between humans and animals. The test also is being used to track the flow of genetic elements in food production systems, such as feedlots. However, Dr. Narayanan hopes the test could soon be used to enhance the clinical diagnosis of animal and human infections.

Related Links:
Kansas State University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: GRAIL’s Galleri test uses machine learning to analyze cfDNA patterns for cancer signals and predict their likely location to guide further evaluation.

Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options

Many lethal cancers lack routine screening and are often diagnosed only after symptoms emerge, limiting curative options. Standard programs in the United States cover a small subset of malignancies, leaving... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.